Recently, a fusion transcript of CD63–BCAR4 was also reported in a comprehensive genomic study of Chinese NSCLC patients.31 Wang et al. identified that a never-smoking female patient with lung adenocarcinoma harboured a CD63–BCAR4 fusion, similar to the fusion described in the present study. This evidence concerns the gene CD63 and lung adenocarcinoma.